News

Lytus Announces the Closing of Initial Public Offering

Mumbai, India, June 17, 2022 (GLOBE NEWSWIRE) -- Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) (the “Company”), a platform technology…

2 years ago

UrgentMED Acquires Urgent Care 3D to Expand High-Quality and Accessible Healthcare Across Southern California

Largest Acquisition to Date Will Provide Greater Access to Patient-Centered Care with Streamlined ServicesLOS ANGELES, CA / ACCESSWIRE / June…

2 years ago

CDHA Meets with Federal Health Minister

Ottawa, Ontario--(Newsfile Corp. - June 17, 2022) - In a virtual roundtable with select professional association leaders convened by the…

2 years ago

Awakn Life Sciences to Present in Upcoming June 2022 Conferences

Toronto, Ontario--(Newsfile Corp. - June 17, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a…

2 years ago

NuGen Announces Results of its Annual and Special Meeting and Approval of Amendments to Stock Option Plan

TORONTO, ON / ACCESSWIRE / June 17, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD) (the "Company") is pleased to announce…

2 years ago

Moderna Receives FDA Authorization for Emergency Use of Its COVID-19 Vaccine for Children 6 Months of Age and Older

mRNA-1273 was authorized for children and adolescents aged 6 months through 17 years of age, administered as two doses given…

2 years ago

Jupiter Wellness Announces the Retirement of Approximately 10% of its Outstanding Shares

JUPITER, FL / ACCESSWIRE / June 17, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced the purchase and retirement of…

2 years ago

BioCorRx Featured on LiveNOW from FOX

ANAHEIM, CA, June 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and…

2 years ago

Sana Biotechnology Presents Data at ISSCR 2022 Annual Meeting Showing Survival of Transplanted Hypoimmune iPSC-Derived Differentiated Cell Types Without Immunosuppression in Non-Human Primates

First demonstration of the survival of allogeneic islet cells, cardiomyocytes, and retinal pigment epithelium cells transplanted into an immunocompetent non-human…

2 years ago

Capricor Therapeutics to Present One-Year Efficacy Results from its Ongoing HOPE-2 Open Label Extension Study at 2022 Parent Project Muscular Dystrophy Annual Conference

Results to be Presented in Late-Breaking SessionSAN DIEGO, June 17, 2022 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company…

2 years ago